Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly
Publishing timestamp: 2023-03-14 16:27:01
Summary
Novo Nordisk plans to cut the price of several insulin drugs by up to 75% in the US, becoming the latest drugmaker to make sharp price cuts after years of public outrage over the high cost of diabetes care. The price changes will go into effect on Jan. 1, 2024, and will cover insulins that come in vials and injection pens. The move comes after insulin manufacturers faced years of pressure from lawmakers to make the lifesaving hormone more affordable for people with diabetes.
Sentiment: POSITIVE
Tickers: LLY, NOVO.B-DK, SAN-FR, SNY, NVO,
Keywords: health care industry, biotech and pharmaceuticals, joe biden, business news, biotechnology, united states, breaking news, pharmaceuticals, novo nordisk a/s, bernie sanders, eli lilly and co, breaking news: business, politics, sanofi sa,